肿瘤细胞治疗研究
ALL SOURCES
Radiotherapy Enhances the Oncolytic Efficacy of the Novel Oncolytic Herpesvirus VG161 and Amplifies Its Antitumor Immunity in Breast Cancer.
我们的研究结果表明，VG161与RT联合的最佳方案是在VG161感染后6小时给予5 Gy照射，这能确保RT最大程度地促进VG161在BC中的复制。
Recent Advances in Tumor-Infiltrating Lymphocyte Therapy for Melanoma.
黑色素瘤是侵袭性最强的皮肤癌形式，并且仍然是皮肤癌相关死亡率的主要原因。
Novel tumor-infiltrating lymphocytes therapy in solid tumors: latest updates from 2025 ASCO annual meeting.
TIL（肿瘤浸润淋巴细胞）疗法作为过继性细胞疗法（ACT）中极具前景的一种形式，已在治疗晚期黑色素瘤方面取得成功。
The trinity of T cell engagement: navigating the molecular and clinical landscape of CAR-T, TILs, and TCEs in the war against cancer.
癌症免疫疗法的出现从根本上重构了肿瘤学范式，从直接靶向肿瘤细胞动力学的药物转向赋能宿主免疫系统识别和清除恶性肿瘤的策略。
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in
TIL（肿瘤浸润淋巴细胞）疗法的全部潜力一直受制于 TIL 活化不足、持久性低以及肿瘤新抗原呈递效率低下。
Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC.
既往研究发现，溶瘤病毒（OVs）可提高 TIL 过继疗法在口腔癌、结肠癌和胰腺癌中的疗效。
Innovative immunotherapeutic strategies for thyroid cancer: challenges and opportunities.
甲状腺癌是全球第七大常见癌症，发病率和死亡率不断上升。
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
TNBC仅占新发乳腺癌诊断的约15%-20%；
Prognostic and therapeutic TILs of cervical cancer-Current advances and future perspectives.
宫颈癌是全球女性最主要的致死性癌症之一。
共 10 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
